AbCellera Biologics Inc (ABCL)
2.83
-0.12
(-4.07%)
USD |
NASDAQ |
Nov 26, 16:00
2.84
+0.01
(+0.35%)
After-Hours: 06:53
AbCellera Biologics Shareholders Equity (Quarterly): 1.078B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.078B |
| June 30, 2024 | 1.111B |
| March 31, 2024 | 1.130B |
| December 31, 2023 | 1.152B |
| September 30, 2023 | 1.183B |
| June 30, 2023 | 1.195B |
| March 31, 2023 | 1.208B |
| December 31, 2022 | 1.233B |
| September 30, 2022 | 1.250B |
| Date | Value |
|---|---|
| June 30, 2022 | 1.213B |
| March 31, 2022 | 1.208B |
| December 31, 2021 | 1.026B |
| September 30, 2021 | 953.40M |
| June 30, 2021 | 967.68M |
| March 31, 2021 | 957.12M |
| December 31, 2020 | 830.51M |
| September 30, 2020 | 89.24M |
| December 31, 2019 | 10.25M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
10.25M
Minimum
Dec 2019
1.250B
Maximum
Sep 2022
988.62M
Average
1.120B
Median
Shareholders Equity (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 388.00M |
| Edesa Biotech Inc | 2.867M |
| Lexaria Bioscience Corp | 10.12M |
| InMed Pharmaceuticals Inc | 8.395M |
| Xenon Pharmaceuticals Inc | 797.81M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.393B |
| Total Liabilities (Quarterly) | 314.73M |
| Current Ratio | 9.336 |